FDA Corrects Rule to Exempt Manufacturers of Certain INDs from Registration

Drug Industry Daily
Manufacturers of investigational new drugs intended for research, teaching or chemical analysis do not have to register their establishments with the FDA, according to a revised final rule on the electronic registration of foreign and domestic facilities.

To View This Article:


Subscribe To Drug Industry Daily